Physician profile
Ramon Suarez
NPI 1548217888
$527.67
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $426 · 2020: $62.90 · 2024: $38.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $38.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $38.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $83.14 | 2019 | |
| Pbg Puerto Rico LLC | $65.66 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $58.75 | 2019-2020 | |
| Medtronic, INC. | $38.34 | 2024 | Interstim |
| Therapeuticsmd, INC. | $35.96 | 2019 | |
| Amgen INC. | $35.75 | 2019 | |
| Amag Pharmaceuticals, INC. | $32.09 | 2019 | |
| Boston Scientific Corporation | $19.25 | 2019 | |
| Roche Diagnostics Corporation | $19.00 | 2019 | |
| Daiichi Sankyo INC. | $18.88 | 2019 | |
| Pfizer Pharmaceuticals LLC | $18.03 | 2019 | |
| Pfizer INC. | $17.23 | 2019 | |
| Aspira Women'S Health INC | $16.45 | 2019 | |
| Astellas Pharma US INC | $15.40 | 2019 | |
| Covidien Lp | $15.21 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $13.56 | 2019 | |
| Mylan Pharmaceuticals INC. | $13.46 | 2019 | |
| Hologic Sales and Service, LLC | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ramon Suarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.